Filter by: patients
What is Halobetasol topical?

Halobetasol is used to treat swelling, inflammation, and itching associated with skin conditions such as eczema, dermatitis, rashes, insect bites, poison ivy, and allergies. Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Allergic contact dermatitis 2 0
Psoriasis 2 1 Efficacy_slight
Lichen Sclerosus 1 0
Lichen planopilaris 1 1 Efficacy_moderate
Eczema 1 0

See all 6 patients currently taking Halobetasol topical

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
3

Reported Dosages

  0.05% as needed as needed 0.05 g m,w,f 0.05 g daily 0.1 g daily
  3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Halobetasol topical (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 50%
Course of treatment ended 1   Course of treatment ended: 50%

See all 2 patients who’ve stopped taking Halobetasol topical

Currently Taking Halobetasol topical

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Halobetasol topical

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Halobetasol topical

Always
1 33%
Usually
2 67%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Halobetasol topical

Very
0 0%
Somewhat
1 33%
A little
1 33%
Not at all
1 33%

Cost

Paid out of pocket

Cost of Halobetasol topical

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.